Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
 |
|
as soon as is submitted to ZB.
Novel combinatorial therapies involving leptin: Opportunities for mechanistic advances and therapeutic translation in human diseases,
In: Leptin : Regulation and Clinical Applications. 2015. 267-279
The escalating prevalence of obesity represents an increasing socioeconomic burden for international health care systems. So far, pharmacological anti-obesity therapies were overall incapable of tackling the obesity epidemic. The development of novel pharmacotherapies that improve systems metabolism in a safe yet efficient manner is of increasing global priority. Novel polypharmacological approaches, that are based either on adjunctive administration of several hormones or on combination of several hormones into single molecules, have shown a remarkable success in reversing metabolic alterations associated with the metabolic syndrome. The aim of this chapter is to summarize recent advances in preclinical and clinical approaches that employ novel combinations of leptin and other drugs, hormones, and biogenic peptides.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Edited volume or book chapter
Editors
Dagogo-Jack, S.*
Book Volume Title
Leptin : Regulation and Clinical Applications
Quellenangaben
Pages: 267-279
Non-patent literature
Publications
Institute(s)
Institute of Diabetes and Obesity (IDO)